Collaborations
i2.JP support partners to connect with each other for developing new opportunities for collaboration. In this page, you will find our recent activities, events, and case studies on partner collaboration. Please feel free to contact us for partner contacts and further details about our activities and case studies.
Case
-

The Challenge: “Medication Adherence in Nogata City, Fukuoka Prefecture”, Exploring the Root Causes and Seeking Solutions!
Astem×Bridge×i2.JP -

Roundtable Talk
"Thinking about the use of open innovation by local governments/organizations"Matsumoto Health Lab x QUINTBRIDGE x i2.JP -

A partnership between a Singaporean startup and a Japanese imaging CRO to tackle challenges surrounding inhaled drug therapies
Meracle x Micron -

The presenters, reverse pitch topics, and participants are all diverse! A collection of unique players create collective knowledge across disciplines
LINK-J ×i2.JP×QUINTBRIDGE -

JTB×AZ
After the company-wide project taxi company's own COPD awareness campaign is underway (Part2)JTB -

JTB×AZ
Educational activities at a taxi company to raise awareness of COPD among those at risk and encourage them to seek medical attention (Part1)JTB -

~Celebrating the 4th anniversary of “i2.JP”~
As a pioneer in co-creation for healthcare to achieve "patient-centered" social implementation with "diversity" and "collective intelligence”President and Representative Director of AstraZeneca K. K. -

Fujitsu×AZ
Co-create ideas as "One Team" for new projects that address patient issues.Fujitsu -

Ask our partners: Matching via i2.JP
Co-creation & innovation begin with "talking"! The unexpected turns reveal new themes and insightsMedical Principle Co., Ltd. -

Carepro x AZ
Ovarian Cancer Awareness Project (Part2)
Seminar collaborating with influencers to reach those less interested in ovarian cancerCarepro -

OiTr×AZ
Ovarian Cancer Awareness Project(Part1)
Restroom signage for the high-risk population, with surveys to explore behavior changeOiTr -

Looking for partners to take on challenges together!- Business matching event to celebrate the 3rd anniversary of i2.JP
CIC Tokyo × QUINTBRIDGE × i2.JP -

PREVENT x AZ(Part2)
Prevent CKD progression - use claims data to track behavior change and quantify the effectiveness of the awareness letterPREVENT Inc. -

PREVENT x AZ(Part1)
A data-driven approach to change behavior of those at risk for chronic kidney disease (CKD)PREVENT Inc. -

Life Course Design Consortium x Lanex
Aiming to realize patient-centric healthcare, take data integration and utilization one step furtherLife Course Design Consortium x Lanex -

ExaWizards x AZ
Challenge in developing App that tracks potassium level in a mealExaWizards -

i2.JP Partner Collaboration Cases
Moving forward, online consultation among doctors, utilization of health and medical data, and App development using weather data(Japanese Only)i2.JP -

Celebrating the i2.JP 2nd Anniversary
(Japanese only)i2.JP -

Realizing Patient-Centric Healthcare through DX and Co-Creation
(Japanese only)i2.JP -

Konica Minolta x AZ
Explore New Solurtion for Prostate Cncer Postoperative PatientsKonica Minolta -

I'mbesideyou x AZ
there has been a need for change in the areas of talent development and trainingI'mbesideyou -

Sugi Pharmacy x AZ
Co-creation between pharmaceutical company and pharmacy!Sugi Pharmacy -

Osaka Innovation Hub x AZ
Deep dive into Public-Private Partnership (PPP)!Osaka Innovation Hub -

Celebrating the 1st Anniversary:The World We Aspire to Through "i2.JP"
Former AZ President -

Eli Lilly x Bayer x Deloitte x AZ
Why do major pharmas collaborate?Major Pharmas -

Welby x AZ
“Medication and Self-Management App” for cancer patientsWelby Inc. -

Ubie×AZ
New challenge to deliver awareness for potential asthma patients by “AI-powered questionnaire”Ubie, Inc. -

MICIN×AZ
New medical challenge together with the “telemedicine tech venture”MICIN, Inc.
※The information in this article was current at the time of the interview. Please note that affiliations, etc. may differ from today.
For inquiries
Interested in joining us?
Thank you for your interest. We will get in touch soon.
